Skip to main content

CMV and Renal Allograft Survival

  • Conference paper
Host Defenses to Intracellular Pathogens

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 162))

  • 85 Accesses

Abstract

A majority of renal transplant recipients become actively infected witb cytomegalovirus (CMV) (1). Most patients displaying CMV antibody preoperatively experience infections due to reactivation of latent virus. Primary CMV infections occur in preoperatively seronegative recipients due to organs from seropositive donors or to blood transfusions (2). CMV infection has serious consequences, including acute allograft rejection and patient death (1). Although CMV infection in renal allograft recipients has been thought to be associated with rejection and graft loss, there is little information concerning the relationship between tissue typing for HLA A, B and DR antigens, CMV infection, and renal allograft survival (3). In the present study the effect of CMV infection on the success of renal transplantation was assessed by serologic analysis of recipients before and following transplantation. Recipients were grouped based on the degree of incompatibility for HLA A, B and DR antigens with their donors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Simmons, R.L., Matas, A.J., Rattazzi, L.C., Balfour, Jr., H.H., Howard, R.J. and Najarian, J.S. (1977). Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery, 82:537–546.

    PubMed  CAS  Google Scholar 

  2. Andrus, C.H., Betts, R.F., May, A.G. and Freeman, R.B. (1976). Cytomegalovirus infection blocks the beneficial effect of pretransplant blood transfusions on renal allograft survival. Transplantation 28:451–456.

    Google Scholar 

  3. May, A.G., Betts, R.F., Freeman, R.B. and Andrus, C.H. (1978). An analysis of cytomegalovirus infection and HLA antigen matching on the outcome of renal transplantation. Ann. Surg. 187:110–117.

    Article  PubMed  CAS  Google Scholar 

  4. Staff, Transplantation and Immunology Branch (1979). NIH microlymphocytotoxicity technique, p. 39, In: NIAID Manual of tissue typing techniques, Ray, J.G. (ed.) Government Printing Office, Washington, D.C. (NIH publication No. 80–545).

    Google Scholar 

  5. Ayoub, G., Park, M.S., Terasaki, P.I. and Iwaki, Y. (1980). B. cell antibodies and cross-matching. Transplantation 29:227–229.

    Article  PubMed  CAS  Google Scholar 

  6. Kerman, R.H., Kahan, B.D. (in press). Immunological evaluation of transplant rejection: Pre-and postoperative indices detecting immune responsiveness, In: Hayry, P. (ed.): Present and Future Trends in Clinical Transplantation, Annals of Clinical Research.

    Google Scholar 

  7. Reynolds, D.W., Stagno, S. and Alford, C.A. (1980). Laboratory diagnosis of cytomegalovirus infection, p. 425, In: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, Lennette, E. and Schmidt, N.V. (eds.) Amer. Pub. Hlth. Assoc, Washington, D.C.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Plenum Press, New York

About this paper

Cite this paper

Kerman, R.H., Conklin, R., Cahall, D., Van Buren, C.T., Kahan, B.D. (1983). CMV and Renal Allograft Survival. In: Eisenstein, T.K., Actor, P., Friedman, H. (eds) Host Defenses to Intracellular Pathogens. Advances in Experimental Medicine and Biology, vol 162. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4481-0_48

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4481-0_48

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4483-4

  • Online ISBN: 978-1-4684-4481-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics